glp 1 agonists in development GLP-1 Market Report 2025-2033, By Product, Molecule, and Geo Current Insights, Advantages and Challenges
Description
A new era for weight loss
Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).
start in minutes.
Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism
